Back to Search Start Over

The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: a systematic review and meta-analysis

Authors :
Stefanou, Maria-Ioanna
Palaiodimou, Lina
Katsanos, Aristeidis H.
Milionis, Haralampos
Kosmidou, Maria
Lambadiari, Vaia
Halvatsiotis, Panagiotis
Ferentinos, Panagiotis
Andreadou, Elizabeth
Marinos, Georgios
Theodorou, Aikaterini
Tzartos, John S
Voumvourakis, Konstantinos
Tsivgoulis, Georgios
Giannopoulos, Sotirios
Source :
Multiple Sclerosis and Related Disorders; 20210101, Issue: Preprints
Publication Year :
2021

Abstract

•In RRMS we detected no benefit from statin treatment as add-on to IFN-β.•Combination of statins with IFN-β was safe and well-tolerated.•Potential beneficial effects in SPMS, CIS and ON warrant further evaluation in future RCTs.

Details

Language :
English
ISSN :
22110348
Issue :
Preprints
Database :
Supplemental Index
Journal :
Multiple Sclerosis and Related Disorders
Publication Type :
Periodical
Accession number :
ejs58237486
Full Text :
https://doi.org/10.1016/j.msard.2021.103395